Prevalence of neurocognitive dysfunction and associated risk factors among follow-up diabetic type 2 patients in diabetes center of Al-Thawra hospital, Sana’a, Yemen - Scorecard - MDSpire
Advertisement
Prevalence of neurocognitive dysfunction and associated risk factors among follow-up diabetic type 2 patients in diabetes center of Al-Thawra hospital, Sana’a, Yemen
Clinical Scorecard: Assessment of Neurocognitive Impairment and Contributing Risk Factors in Type 2 Diabetes Patients at Al-Thawra Hospital, Sana’a, Yemen
At a Glance
Category
Detail
Condition
Type 2 Diabetes Mellitus and Neurocognitive Dysfunction
Key Mechanisms
Hyperglycemia, insulin resistance, oxidative stress, and cardiovascular complications.
Target Population
Patients aged 35 to 65 years with Type 2 Diabetes Mellitus.
Care Setting
Diabetes center of Al-Thawra public hospital
Key Highlights
43% prevalence of neurocognitive dysfunction among T2DM patients.
Higher prevalence in elderly, low-educated, non-employed, and long-duration diabetes patients.
Significant decrease in neurocognitive dysfunction in patients with low BMI and those who exercise regularly.
Guideline-Based Recommendations
Diagnosis
Use Mini-Mental State Examination (MMSE) for screening neurocognitive dysfunction.
Management
Control blood glucose levels to delay cognitive decline.
Monitoring & Follow-up
Regular assessment of cognitive function in T2DM patients.
Risks
Increased risk of cognitive impairment associated with hypertension, obesity, and cardiovascular diseases.
Patient & Prescribing Data
Yemeni patients with Type 2 Diabetes Mellitus.
Focus on glycemic control and management of associated risk factors.
Clinical Best Practices
Encourage regular exercise and weight management.
Monitor cognitive function regularly in diabetic patients.
